LIDONEX

LIVE

Serial Number

97296250

Owner

NEWPHARMA, INC.

Attorney

Eric T Fingerhut

First Use Date

Sep 22, 2022

Filing Date

Mar 4, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

LIDONEX Trademark

Serial Number: 97296250 • Registration: 7018553

LIDONEX is a trademark filed by NEWPHARMA, INC. on March 4, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

NEWPHARMA, INC. (14 trademarks)

3307 NORTHWEST 74TH AVENUE
MIAMI, FL 33122

Entity Type: 03

New Pharma, Inc. (13 trademarks)

3307 NW 74th Avenue
Miami, FL 33122

Entity Type: 03

Aldama Pharmaceuticals, Inc. (17 trademarks)

3307 NW 74th Avenue
Miami, FL 33122

Entity Type: 03

Legal Representation

Attorney of Record

Eric T Fingerhut

2,634 trademarks filed View all →

Correspondence Address

Eric T. Fingerhut DYKEMA GOSSETT PLLC

1301 K STREET, N.W.

SUITE 1100 WEST

WASHINGTON, DC 20005

UNITED STATES

Trademark Details

Filing Date

March 4, 2022

Registration Date

April 4, 2023

First Use Anywhere

September 22, 2022

First Use in Commerce

September 22, 2022

Published for Opposition

January 17, 2023

Goods & Services

Pain relief medication

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Sep 24, 2025 ASGN

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 4, 2023 NRCC

REGISTERED-PRINCIPAL REGISTER

Apr 4, 2023 R.PR

ASSIGNMENT OF OWNERSHIP UPDATED MANUALLY

Mar 9, 2023 AOUM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 17, 2023 NPUB

PUBLISHED FOR OPPOSITION

Jan 17, 2023 PUBO

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Jan 4, 2023 ASCK

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 28, 2022 NONP

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Dec 16, 2022 AAUA

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 15, 2022 CNSA

USE AMENDMENT ACCEPTED

Dec 15, 2022 IUAA

ASSIGNED TO EXAMINER

Dec 15, 2022 DOCK

AMENDMENT TO USE PROCESSING COMPLETE

Oct 19, 2022 AUPC

USE AMENDMENT FILED

Oct 19, 2022 IUAF

TEAS AMENDMENT OF USE RECEIVED

Oct 18, 2022 EAAU

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 9, 2022 NWOS

NEW APPLICATION ENTERED

Mar 8, 2022 NWAP

Related Trademarks

More from this Owner

ALDAMA PHARMACEUTICALS

ALDAMA PHARMACEUTICALS, INC.

RENALVIT

GUAIFED

More in Same Class

IMMUNOMIC THERAPEUTICS